A carregar...
Diffuse Hypopigmentation Followed by Hyperpigmentation in an African American Woman with Hemangiopericytoma Treated with Dasatinib
Dasatinib is a second-generation multi-target tyrosine kinase inhibitor (TKI) that has activity against many imatinib-resistant BCR-ABL mutant forms, Src, and c-Kit tyrosine kinases. While skin hypopigmentation is a well recognized adverse effect of first generation TKIs; it has rarely been reported...
Na minha lista:
| Publicado no: | J Clin Diagn Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
JCDR Research and Publications (P) Limited
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4290303/ https://ncbi.nlm.nih.gov/pubmed/25584281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/8055.5160 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|